MoneyWorks4Me

Granules India - Quaterly Results

16 May 2023 Evaluate
The revenue zoomed 11.07% to Rs. 10138.75 millions for the quarter ended March 2023 as compared to Rs. 9128.48 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 1252.89  millions from Rs. 1292.44 millions ,decline by -3.06%.Operating Profit saw a handsome growth to 2198.57 millions from 2102.48 millions in the quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 10138.75 9128.48 11.07 39312.00 32384.37 21.39 39312.00 32384.37 21.39
Other Income 25.61 42.79 -40.15 99.32 175.11 -43.28 99.32 175.11 -43.28
PBIDT 2198.57 2102.48 4.57 8481.71 6621.60 28.09 8481.71 6621.60 28.09
Interest 141.19 40.01 252.89 386.74 163.52 136.51 386.74 163.52 136.51
PBDT 2057.38 2062.47 -0.25 8094.97 6458.08 25.35 8094.97 6458.08 25.35
Depreciation 377.69 316.83 19.21 1455.57 1261.61 15.37 1455.57 1261.61 15.37
PBT 1679.69 1745.64 -3.78 6639.40 5196.47 27.77 6639.40 5196.47 27.77
TAX 426.80 453.20 -5.83 1651.55 1331.31 24.05 1651.55 1331.31 24.05
Deferred Tax 12.34 11.44 7.87 -50.51 -3.76 1243.35 -50.51 -3.76 1243.35
PAT 1252.89 1292.44 -3.06 4987.85 3865.16 29.05 4987.85 3865.16 29.05
Equity 242.04 248.01 -2.41 242.04 248.01 -2.41 242.04 248.01 -2.41
PBIDTM(%) 21.68 23.03 -5.85 21.58 20.45 5.52 21.58 20.45 5.52
Peers
Company Name CMP
Sun Pharma. Inds. 1853.15
Dr. Reddys Labs. 1190.20
Cipla 1374.60
Lupin 2087.65
Zydus Lifesciences 1154.80
View more..